1.      Akay, A. P., & Ercan, E. S. (2016). Çocuk ve ergen ruh sağlığı ve hastalıkları (pp. 33–56). Türkiye Çocuk ve Genç Psikiyatrisi Derneği.

2.      American Psychiatric Association. (1967). Diagnostic and statistical manual for mental disorders (2nd ed.). American Psychiatric Association.

3.      American Psychiatric Association. (1980). Diagnostic and statistical manual for mental disorders (3rd ed.). American Psychiatric Association.

4.      American Psychiatric Association. (1987). Diagnostic and statistical manual for mental disorders (3rd ed., rev.). American Psychiatric Association.

5.      American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing.

6.      Arnsten, A. F. (2009). Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: An important role for prefrontal cortex dysfunction. CNS Drugs, 23 (Suppl 1), 33–41.

7.      Arnsten, A. F., & Pliszka, S. R. (2011). Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders. Pharmacology Biochemistry and Behavior, 99(2), 211–216.

8.      Biederman, J., Monuteaux, M., Mick, E., et al. (2006). Young adult outcome of attention deficit hyperactivity disorder: A controlled 10-year prospective follow-up study. Psychological Medicine, 36(2), 167–179.

9.      Bonati, M., Reale, L., Zanetti, M., et al. (2018). A regional ADHD center-based network project for the diagnosis and treatment of children and adolescents with ADHD. Journal of Attention Disorders, 22(12), 1173–1184.

10.  Caballero, J., & Nahata, M. C. (2003). Atomoxetine hydrochloride for the treatment of attention-deficit/hyperactivity disorder. Clinical Therapeutics, 25(12), 3065–3083.

11.  Cortese, S. (2012). The neurobiology and genetics of attention-deficit/hyperactivity disorder (ADHD): What every clinician should know. European Journal of Paediatric Neurology, 16(5), 422–433.

12.  Cortese, S., Imperati, D., Zhou, J., et al. (2013). White matter alterations at 33-year follow-up in adults with childhood attention-deficit/hyperactivity disorder. Biological Psychiatry, 74(8), 591–598.

13.  DuPaul, G. J., Gormley, M. J., & Laracy, S. D. (2013). Comorbidity of LD and ADHD: Implications of DSM-5 for assessment and treatment. Journal of Learning Disabilities, 46(1), 43–51.

14.  Elia, J., Ambrosini, P. J., & Rapoport, J. L. (1999). Treatment of attention-deficit-hyperactivity disorder. New England Journal of Medicine, 340(10), 780–788.

15.  Ercan, E. S., Kandulu, R., Uslu, E., et al. (2013). Prevalence and diagnostic stability of ADHD and ODD in Turkish children: A 4-year longitudinal study. Child and Adolescent Psychiatry and Mental Health, 7(1), 30.

16.  Faraone, S. V., Larsson, H. (2019). Genetics of attention deficit hyperactivity disorder. Molecular Psychiatry, 24(4), 562–575.

17.  Faraone, S. V., Mick, E. (2010). Molecular genetics of attention deficit hyperactivity disorder. Psychiatric Clinics of North America, 33(1), 159–180.

18.  Faraone, S. V., Perlis, R. H., Doyle, A. E., et al. (2005). Molecular genetics of attention-deficit/hyperactivity disorder. Biological Psychiatry, 57(11), 1313–1323.

19.  Gizer, I. R., Ficks, C., & Waldman, I. D. (2009). Candidate gene studies of ADHD: A meta-analytic review. Human Genetics, 126(1), 51–90.

20.  Gnanavel, S., Sharma, P., Kaushal, P., & Hussain, S. (2019). Attention deficit hyperactivity disorder and comorbidity: A review of literature. World Journal of Clinical Cases, 7(17), 2420–2426.

21.  Gul, N., Tiryaki, A., & Cengel Kultur, S. E. (2010). Prevalence of attention deficit hyperactivity disorder and comorbid disruptive behavior disorders among school age children in Trabzon. Klinik Psikofarmakoloji Bulteni, 20(1), 50–56.

22.  Kutlu, A., & Binici, N. C. (2017). The prevalence of attention deficit hyperactivity disorder and the frequency of medication use among preschool children. İzmir Dr. Behçet Uz Çocuk Hastanesi Dergisi, 7(1), 15–21.

23.  Langley, K., Fowler, T., Ford, T., et al. (2010). Adolescent clinical outcomes for young people with attention-deficit hyperactivity disorder. British Journal of Psychiatry, 196(3), 235–240.

24.  Leitner, Y. (2014). The co-occurrence of autism and attention deficit hyperactivity disorder in children: What do we know? Frontiers in Human Neuroscience, 8, 268.

25.  Li, Z., Chang, S. H., Zhang, L. Y., et al. (2014). Molecular genetic studies of ADHD and its candidate genes: A review. Psychiatry Research, 219(1), 10–24.

26.  Millichap, J. G. (2008). Etiologic classification of attention-deficit/hyperactivity disorder. Pediatrics, 121(2), e358–e365.

27.  Mukaddes, N. M. (2015). Yaşam boyu dikkat eksikliği ve hiperaktivite bozukluğu ve eşlik eden durumlar. Nobel Tıp Kitabevleri.

28.  Mukaddes, N. M., Ercan, E. (2018). Nörogelişimsel bozukluklar (pp. 35–115). Nobel Tıp Kitabevleri.

29.  Neale, B. M., Lasky-Su, J., Anney, R., et al. (2008). Genome-wide association scan of attention deficit hyperactivity disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 147B(8), 1337–1344.

30.  Nigg, J. T. (2013). Attention-deficit/hyperactivity disorder and adverse health outcomes. Clinical Psychology Review, 33(2), 215–228.

31.  Pliszka, S. (2007). Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 46(7), 894–921.

32.  Polanczyk, G., Lima, M. S., Horta, B. L., et al. (2007). The worldwide prevalence of ADHD: A systematic review and metaregression analysis. American Journal of Psychiatry, 164(6), 942–948.

33.  Reale, L., Bartoli, B., Cartabia, M., et al. (2017). Comorbidity prevalence and treatment outcome in children and adolescents with ADHD. European Child & Adolescent Psychiatry, 26(12), 1443–1457.

34.  Spencer, T. J., Biederman, J., & Mick, E. (2007). Attention-deficit/hyperactivity disorder: Diagnosis, lifespan, comorbidities, and neurobiology. Journal of Pediatric Psychology, 32(6), 631–642.

35.  Sprich, S., Biederman, J., Crawford, M. H., et al. (2000). Adoptive and biological families of children and adolescents with ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 39(11), 1432–1437.

36.  Stahl, S. M. (2013). Stahl's essential psychopharmacology (4th ed., pp. 471–502). Cambridge University Press.

37.  Staller, J., & Faraone, S. V. (2006). Attention-deficit hyperactivity disorder in girls: Epidemiology and management. CNS Drugs, 20(2), 107–123.

38.  Willcutt, E. G. (2012). The prevalence of DSM-IV attention-deficit/hyperactivity disorder: A meta-analytic review. Neurotherapeutics, 9(3), 490–499.

39.  Willcutt, E. G., Doyle, A. E., Nigg, J. T., Faraone, S. V., & Pennington, B. F. (2005). Validity of the executive function theory of attention-deficit/hyperactivity disorder: A meta-analytic review. Biological Psychiatry, 57(11), 1336–1346.